Care
Telehealth company Caregility, hybrid cancer care company Daymark Health and virtual care company AmplifyMD also garnered funding.
The company will use the funds to expand Dreem Health, scale nationwide and advance its FDA-cleared sleep apnea technology.
The Series D funding brings the company’s total raise to $275 million and its valuation to more than $1 billion.
The company stated Capital Rx will still operate as its pharmacy benefits manager brand under Judi Health.
The funds will be used to expand its customer base and invest in AI innovation.
At an event in Washington, D.C., on Monday, DiMe released a thesis with what it says are four impact areas that are vital to pursue in digital medicine in the next five years.
IBM will help Infinitus apply agentic AI into specialty pharmacy workflows.
The company's new offering XR CareCart provides real-time immersive care in multiple locations.
The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.
Also, Vuno has sold its bone age AI as part of ongoing restructuring.